Sarepta Therapeutics, Inc. (SRPT)

23.35 +0.20 (+0.86%) USD  |  NASDAQ  |  Jan 09, 11:34
More

Sarepta Therapeutics Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade